Skip to main content

Market Overview

Hi-Tech Pharmacal Announces $25M Settlement Regarding Texas Pricing Investigation


Hi-Tech Pharmacal
(NASDAQ: HITK) today announced that the Texas
Attorney General has agreed to close its investigation of Hi-Tech's
pricing of products that were purchased with Texas Medicaid dollars. In
settlement, Hi-Tech agreed to pay $25,000,000 to the State of Texas.
This amount had previously been accrued in the Company's financial
statements. The settlement does not constitute an admission, finding or
evidence of any liability or wrongdoing by Hi-Tech.

See full press release


Related Articles (HITK)

View Comments and Join the Discussion!

Posted-In: News Guidance Financing Offerings Legal Global

Need corporate guidance data?
Click here to see licensing options.
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at